Soleno reports death of patient who took genetic disorder treatment

Soleno Therapeutics

10/09/2025 17:43

Sept 10 (Reuters) - Soleno Therapeutics SLNO.O reported on Wednesday the death of a 17 year old male who was on the company's treatment for patients who experience feelings of intense and persistent hunger.

The company said the treating physician has reported that the death is not related to the treatment.

 (Reporting by Christy Santhosh in Bengaluru; Editing by Alan Barona)

 ((Christy.Santhosh@thomsonreuters.com))